Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 541 AL 555

Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases

Lizama BN, Kahle J, Catalano SM, Caggiano AO, Grundman M, Hamby ME.

Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.

Molecular mechanisms of neuroprotective offerings by rosmarinic acid against neurodegenerative and other CNS pathologies

Ravaria P, Saxena P, Laksmi Bs S, Ranjan V, Abidi SWF, Saha P, Ramamoorthy S, Ahmad F, Rana SS.

Phytother Res. 2023 May;37(5):2119-2143. doi: 10.1002/ptr.7825. Epub 2023 Apr 4.

Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration

Khakha N, Khan H, Kaur A, Singh TG.

Pharmacol Rep. 2023 Oct;75(5):1152-1165. doi: 10.1007/s43440-023-00526-9. Epub 2023 Sep 9.

Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine

Jin S, Zhang L, Wang L.

Biomed Pharmacother. 2023 Sep;165:115215. doi: 10.1016/j.biopha.2023.115215. Epub 2023 Jul 24.

Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases

Lustoza Rodrigues TCM, de Sousa NF, Dos Santos AMF, Aires Guimarães RD, Scotti MT, Scotti L.

Curr Top Med Chem. 2023;23(5):349-370. doi: 10.2174/1568026623666230126112628.

Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders

Almikhlafi MA, Karami MM, Jana A, Alqurashi TM, Majrashi M, Alghamdi BS, Ashraf GM.

Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408.

Cyclitols: From Basic Understanding to Their Association with Neurodegeneration

Derkaczew M, Martyniuk P, Osowski A, Wojtkiewicz J.

Nutrients. 2023 Apr 23;15(9):2029. doi: 10.3390/nu15092029.

Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases

Wang Y, Lv MN, Zhao WJ.

Ageing Res Rev. 2023 Nov;91:102035. doi: 10.1016/j.arr.2023.102035. Epub 2023 Aug 22.

Exosomes for the diagnosis and treatment of dementia

Joo HS, Jeon HY, Hong EB, Kim HY, Lee JM.

Curr Opin Psychiatry. 2023 Mar 1;36(2):119-125. doi: 10.1097/YCO.0000000000000842. Epub 2023 Jan 11.

Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis

Sabbagh M, Small GW, Isaacson SH, Torres-Yaghi Y, Pagan F, Pahwa R.

Int J Psychiatry Clin Pract. 2023 Mar;27(1):69-81. doi: 10.1080/13651501.2022.2058406. Epub 2022 May 14.

Recent advances in Lewy body dementia: A comprehensive review

Prasad S, Katta MR, Abhishek S, Sridhar R, Valisekka SS, Hameed M, Kaur J, Walia N.

Dis Mon. 2023 May;69(5):101441. doi: 10.1016/j.disamonth.2022.101441. Epub 2022 Jun 9.

Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

Katta M, Mathew BA, Chaturvedi P, Ludhiadch A, Munshi A.

Neurol Sci. 2023 Jan;44(1):19-36. doi: 10.1007/s10072-022-06356-6. Epub 2022 Sep 6.

Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Edison P.

Mol Psychiatry. 2023 Jan;28(1):217-229. doi: 10.1038/s41380-022-01792-4. Epub 2022 Oct 18.

The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence

Emekli-Alturfan E, Alturfan AA.

Mol Biol Rep. 2023 Jan;50(1):815-828. doi: 10.1007/s11033-022-07925-w. Epub 2022 Nov 3.

Regenerative medicine improve neurodegenerative diseases

Ashraf SS, Hosseinpour Sarmadi V, Larijani G, Naderi Garahgheshlagh S, Ramezani S, Moghadamifar S, Mohebi SL, Brouki Milan P, Haramshahi SMA, Ahmadirad N, Amini N.

Cell Tissue Bank. 2023 Sep;24(3):639-650. doi: 10.1007/s10561-022-10062-0. Epub 2022 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias